All Type 2 diabetes articles
-
eLearning moduleDeep dive on SGLT2 inhibitors with a focus on Jardiance® (empagliflozin)
This eLearning module has been commissioned and funded by the Boehringer Ingelheim and Lilly Diabetes Alliance and developed in partnership with Guidelines in Practice and Guidelines Learning. Products are discussed.
View Jardiance® (empagliflozin) prescribing and adverse event reporting information for Great Britain or Northern Ireland
PC-GB-104397 April 2021 -
Key learning points
Key learning points: diabetes and frailty in older adults
Dr David Strain outlines six key learning points from an expert consensus statement on managing diabetes and frailty, and identifies where treatment should differ from a standard approach
-
On demand webinars
Dipeptidyl peptidase-4 inhibitors—still a major player in type 2 diabetes care
This promotional webinar has been initiated and commissioned by Boehringer Ingelheim Limited and organised in partnership with Guidelines in Practice.
View Trajenta® (linagliptin) prescribing and adverse events reporting information for:
Great Britain
Northern Ireland
PC-GB-103485 | July 2021 -
Supplement
Guideline for the managed introduction of biosimilar bolus insulin in individuals with type 2 diabetes
This working party guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Sanofi Ltd
-
Formulary decision guide
Steglatro®▼ (Ertugliflozin)
This formulary decision guide was developed from content provided by MSD UK Ltd in a format developed by Guidelines in Practice.
View prescribing information and adverse event reporting
GB-STE-00433 | June 2021 -
Formulary decision guide
Trurapi▼ (insulin aspart 100 units/ml)
This formulary decision guide was developed from content provided by Sanofi Ltd in a format developed by Guidelines in Practice.
View prescribing and adverse event reporting information
MAT-GB-2101070(v2.0) | Date of preparation: July 2021 -
Implementing guidelines
Manage diabetes and comorbidities with a joined-up strategy
Dr Umesh Dashora and colleagues from the CaReMeUK Partnership outline guidance on how to manage type 2 diabetes with cardiovascular and renal disease
-
Supplement
Dipeptidyl peptidase-4 inhibitors—still a major player in type 2 diabetes care
This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines in Practice.
View Trajenta® (linagliptin) prescribing and adverse event reporting information
PC-GB-103451 Date of preparation: January 2021 -
Implementing guidelines
Diabetes in chronic kidney disease requires practical, evidence-based care
Dr Pam Brown and Dr Colin Kenny discuss recommendations from a new international guideline on diabetes management in patients with chronic kidney disease
-
Supplement
Showcasing local best practice in diabetes
This Guidelines in Practice supplement aims to showcase local best practice in the diagnosis and management of diabetes. The supplement includes articles from three local initiatives that have developed their own guidance or demonstrated improvements in different areas of diabetes care: Dr David Unwin shares ...
-
Supplement
Diabetes quality improvement at Barking and Dagenham: closing the inequalities gap
Dr Anju Gupta and Richard Clements explain how improvements in the quality of diabetes care were achieved, and variation reduced, in a socioeconomically deprived London borough
-
Supplement
Local, evidence-based guidance: optimising treatment of type 2 diabetes in Birmingham
Professor Wasim Hanif, Dr Nashat Qamar, and Hanadi Alkhder discuss the need for local guidance on non-insulin antidiabetic agents for adults with type 2 diabetes, and the important role played by the multidisciplinary team
-
Supplement
Successful dietary management of type 2 diabetes: experience from Norwood Surgery in Southport
Dr David Unwin shares details of how a GP practice in Liverpool has supported patients to achieve drug-free type 2 diabetes remission through dietary management
-
Implementing guidelines
Type 2 diabetes: maintain glycaemic control to prevent complications
Dr Samuel Seidu and Professor Kamlesh Khunti discuss the recommendations of the Primary Care Diabetes Europe position statement on the management of type 2 diabetes
-
Implementing guidelines
Diagnose and treat pancreatic exocrine insufficiency in diabetes
Dr Kate Millar and Professor Michael Cummings present a summary of guidance that aims to help practitioners to identify and manage pancreatic exocrine insufficiency in people with diabetes
-
Test and reflect
Patient scenarios: diabetes and cardiovascular risk
The following scenarios are fictitious but similar to those experienced by real patients and are designed to help you reflect on what you have learnt after reading the article. They could also be used for group discussion in an education or practice meeting. There are no right or wrong answers ...
-
Supplement
Guideline for the managed introduction of biosimilar basal insulin
This working party guideline was developed by a multidisciplinary expert panel: Down S et al with the support of a grant from Mylan.
-
Test and reflect
Collaborative stakeholder initiative for the management of type 2 diabetes in older people
This CPD activity consists of 3 multiple-choice questions (MCQs) designed to test your knowledge on the management of diabetes in older people, including in the context of frailty.
-
Implementing guidelines
Type 2 diabetes: targets and treatments should be person-centred
Dr Clare Hambling and Dr Patrick Holmes highlight the key recommendations from the joint ADA/EASD consensus report on the management of hyperglycaemia in type 2 diabetes
-
Pharmacist focus
Type 2 diabetes: the role of the practice pharmacist
Muhammad Siddiqur Rahman highlights the integral role of practice-based pharmacists in managing type 2 diabetes
